[
  {
    "criterion": "Mentions the risk of bleeding complications from thromboprophylaxis in patients with mild renal dysfunction",
    "axis": "accuracy",
    "point": 7
  },
  {
    "criterion": "Provides a clear and concise explanation of thromboprophylaxis after total hip arthroplasty",
    "axis": "communication_quality",
    "point": 5
  },
  {
    "criterion": "Does not recommend a specific type of anticoagulant without considering the patient's individual circumstances",
    "axis": "context_awareness",
    "point": 8
  },
  {
    "criterion": "Fails to mention the importance of regular monitoring of international normalized ratio (INR) in patients receiving warfarin",
    "axis": "completeness",
    "point": -5
  },
  {
    "criterion": "Provides a comprehensive overview of thromboprophylaxis options after total hip arthroplasty, including mechanical and pharmacological methods",
    "axis": "completeness",
    "point": 9
  },
  {
    "criterion": "Incorrectly states that thromboprophylaxis is only necessary for patients with severe renal dysfunction",
    "axis": "accuracy",
    "point": -9
  },
  {
    "criterion": "Does not consider the patient's medical history and other medications when recommending thromboprophylaxis",
    "axis": "context_awareness",
    "point": -3
  },
  {
    "criterion": "Provides a clear and actionable recommendation for thromboprophylaxis after total hip arthroplasty",
    "axis": "instruction_following",
    "point": 8
  },
  {
    "criterion": "Mentions the importance of working closely with a healthcare provider to determine the appropriate thromboprophylaxis regimen",
    "axis": "context_awareness",
    "point": 6
  },
  {
    "criterion": "Does not discuss the potential risks and benefits of different thromboprophylaxis options",
    "axis": "completeness",
    "point": -2
  }
]